Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-03-27 | Mr. William L. AshtonIndependent Director | 350,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,36 | 440,00k | 388,89% |
| 2025-12-16 | Mr. Patrick J. MahaffyIndependent Director | 25,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,31 | 50,00k | 100,00% |
| 2025-12-16 | Dr. Raza BokhariCEO & Executive Chairman | 125,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,31 | 675,00k | 22,73% |
| 2025-12-16 | Mr. Ajay RajuDirector | 25,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,31 | 50,00k | 100,00% |
| 2025-12-16 | Mr. Robert Joseph CiaruffoliIndependent Lead Director | 25,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,31 | 90,00k | 38,46% |
| 2025-12-16 | Mr. Andrew Alasdair SmithCOO | 50,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,31 | 150,00k | 50,00% |
| 2025-12-16 | Mr. William L. AshtonIndependent Director | 25,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,31 | 90,00k | 38,46% |
| 2025-12-16 | Dr. Larry R. KaiserIndependent Director | 25,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,31 | 90,00k | 38,46% |
| 2025-12-16 | Dr. Edward J. BrennanChief Scientific Officer and Head of R&D Program | 50,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,31 | 195,00k | 34,48% |
| 2025-12-16 | Dr. Sara R. MayIndependent Director | 25,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,31 | 90,00k | 38,46% |
| 2025-12-16 | Ms. Carolyn BonnerInitié | 75,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,31 | 197,50k | 61,22% |
| 2025-12-16 | Dr. Faisal MehmudChief Medical Officer | 75,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,31 | 225,00k | 50,00% |
| 2025-12-16 | Hon. Cathy McMorris RodgersIndependent Director | 25,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,31 | 50,00k | 100,00% |
| 2025-08-13 | Mr. James P. QuinlanInitié | 145,00k | 162,70k | Derivative Exercise and Retained Stock | 0,84 - 2,87 | 274,15k | 112,27% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
